Net profit of Morepen Laboratories rose 63.92% to Rs 34.85 crore in the quarter ended September 2024 as against Rs 21.26 crore during the previous quarter ended September 2023. Sales rose 3.78% to Rs 437.73 crore in the quarter ended September 2024 as against Rs 421.77 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 437.73 | 421.77 | 4 |
| OPM % | 10.07 | 7.96 | - |
| PBDT | 47.88 | 36.37 | 32 |
| PBT | 46.02 | 28.68 | 60 |
| NP | 34.85 | 21.26 | 64 |